Antibody epitope peptides as potential inducers of IgG antibodies against CD98 oncoprotein

Cancer Science

Volumn 100, Issue 1, 2009, Pages 126-131

  Itoh, Kunihiko ^a   Ohshima, Motohiro ^a   Sonobe, Momoyo ^a   Saito, Misa ^a   Yoshida, Akira ^a   Hayashi, Hideki ^a   Inoue, Kazuyuki ^a   Masuko, Takashi ^b  

^a UNIVERSITY OF SHIZUOKA   (Japan)

^b KINKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BOVINE SERUM ALBUMIN; CD98 ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; KEYHOLE LIMPET HEMOCYANIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY HBJ127; UNCLASSIFIED DRUG;

ACTIVE IMMUNIZATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOPANNING; CONTROLLED STUDY; DRUG DESIGN; DRUG EFFICACY; FEMALE; HELA CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOGENICITY; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOPRECIPITATION; IMMUNOREACTIVITY; MOUSE; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; SPLEEN CELL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; ANTIGENS, CD98; EPITOPES; FEMALE; HELA CELLS; HEMOCYANIN; HUMANS; IMMUNIZATION; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C;

EID: 58149287729     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2008.00998.x     Document Type: Article

References (30)

1. Haynes BF, Hemler ME, Mann DL et al. Characterization of a monoclonal antibody (4F2) that binds to human monocytes and to a subset of activated lymphocytes. J Immunol 1981; 126: 1409-14.
2. Broer S, Broer A, Hamprecht B. The 4F2hc surface antigen is necessary for expression of system 1-like neutral amino acid-transport activity in C6-BU-1 rat glioma cells: Evidence from expression studies in Xenopus laevis oocytes. Biochem J 1995; 312 (Pt 3): 863-70.
3. Kanai Y, Segawa H, Miyamoto K, Uchino H, Takeda E, Endou H. Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98). J Biol Chem 1998; 273: 23.629-32.
4. Hashimoto Y, Masuko T, Yagita H, Endo N, Kanazawa J, Tazawa J. A proliferation-associated rat cell surface antigen recognized by a murine monoclonal antibody. Gann 1983; 74: 819-21.
5. Masuko T, Abe J, Yagita H, Hashimoto Y. Human bladder cancer cell-surface antigens recognized by murine monoclonal antibodies raised against T24 bladder cancer cells. Jpn J Cancer Res 1985; 76: 386-94.
6. Yagita H, Masuko T, Hashimoto Y. Inhibition of tumor cell growth in.vitro by murine monoclonal antibodies that recognize a proliferation-associated cell surface antigen system in rats and humans. Cancer Res 1986; 46: 1478-84.
7. Yagita H, Masuko T, Takahashi N, Hashimoto Y. Monoclonal antibodies that inhibit activation and proliferation of lymphocytes. I. Expression of the antigen on monocytes and activated lymphocytes. J Immunol 1986; 136: 2055-61.
8. Hara K, Kudoh H, Enomoto T, Hashimoto Y, Masuko T. Malignant transformation of NIH3T3 cells by overexpression of early lymphocyte activation antigen CD98. Biochem Biophys Res Commun 1999; 262: 720-5.
9. Goldenberg MM. Trastuzumab, a recombinant DNA-derived humanized monoclonal antibody, a novel agent for the treatment of metastatic breast cancer. Clin Ther 1999; 21: 309-18.
10. Anderson DR, Grillo-Lopez A, Varns C, Chambers KS, Hanna N. Targeted anti-cancer therapy using rituximab, a chimaeric anti-CD20 antibody (IDEC-C2B8) in the treatment of non-Hodgkin's B-cell lymphoma. Biochem Soc Trans 1997; 25: 705-8.
11. Maini RN, Breedveld FC, Kalden JR et al. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. Arthritis Rheum 1998; 41: 1552-63.
12. Riemer AB, Kurz H, Klinger M, Scheiner O, Zielinski CC, Jensen-Jarolim E. Vaccination with cetuximab mimotopes and biological properties of induced anti-epidermal growth factor receptor antibodies. J Natl Cancer Inst 2005; 97: 1663-70.
13. Li M, Yan Z, Han W, Zhang Y. Mimotope vaccination for epitope-specific induction of anti-CD20 antibodies. Cell Immunol 2006; 239: 136-43.
14. Riemer AB, Klinger M, Wagner S et al. Generation of peptide mimics of the epitope recognized by trastuzumab on the oncogenic protein Her-2/ neu. J Immunol 2004; 173: 394-401.
15. Riemer AB, Forster-Waldl E, Bramswig KH et al. Induction of IgG antibodies against the GD2 carbohydrate tumor antigen by vaccination with peptide mimotopes. Eur J Immunol 2006; 36: 1267-74.
16. Bolesta E, Kowalczyk A, Wierzbicki A et al. DNA vaccine expressing the mimotope of GD2 ganglioside induces protective GD2 cross-reactive antibody responses. Cancer Res 2005; 65: 3410-18.
17. Horwacik I, Czaplicki D, Talarek K et al. Selection of novel peptide mimics of the GD2 ganglioside from a constrained phage-displayed peptide library. Int J Mol Med 2007; 19: 829-39.
18. Itoh K, Inoue K, Hayashi H, Suzuki T, Masuko T. Identification of cell proliferation-associated epitope on CD98 oncoprotein using phage display random peptide library. Cancer Sci 2007; 98: 1696-700.
19. Itoh K, Suzuki K, Ishiwata S, Tezuka T, Mizugaki M, Suzuki T. Application of a recombinant Fab fragment from a phage display library for sensitive detection of a target antigen by an inhibition ELISA system. J Immunol Meth 1999; 223: 107-14.
20. Itoh K, Inoue K, Hirooka K et al. Phage display cloning and characterization of monoclonal antibody genes and recombinant Fab fragment against the CD98 oncoprotein. Jpn J Cancer Res 2001; 92: 1313-21.
21. Kabat EA, Wu TT, Perry HM, Gottesman KS, Foeller C. Sequences of Proteins of Immunological Interest. Washington: Department of Health and Human Services, Public Services, NIH, 1991.
22. Barbas CF, Kang AS, Lerner RA, Benkovic SJ. Assembly of combinatorial antibody libraries on phage surfaces: The gene III site. Proc Natl Acad Sci USA 1991; 88: 7978-82.
23. Scherer WF, Syverton JT, Gey GO. Studies on the propagation in vitro of poliomyelitis viruses. IV. Viral multiplication in a stable strain of human malignant epithelial cells (strain HeLa) derived from an epidermoid carcinoma of the cervix. J Exp Med 1953; 97: 695-710.
24. Eggena M, Targan SR, Iwanczyk L, Vidrich A, Gordon LK, Braun J. Phage display cloning and characterization of an immunogenetic marker (perinuclear anti-neutrophil cytoplasmic antibody) in ulcerative colitis. J Immunol 1996; 156: 4005-11.
25. Li M, Han W, Zhang Q, Xue X, Wang Z, Zhang Y. Development of a mimotope-based vaccine against CD20 antigen. Protein Pept Lett 2007; 14: 610-14.
26. Oldstone MB. Molecular mimicry, microbial infection, and autoimmune disease: Evolution of the concept. Curr Top Microbiol Immunol 2005; 296: 1-17.
27. Jerne NK. The somatic generation of immune recognition. Eur J Immunol 1971; 1: 1-9.
28. Fischer EA, Curd JG, Chaiken IM. Preparation of biologically active conjugates of bovine neurophysins and other polypeptides with multi-(poly-D,1-alanyl)-poly-L-lysine and their use to elicit antibodies. Immunochemistry 1977; 14: 595-602.
29. Harper S, Speicher DW. In: Coligan JE, Dunn BM, Ploegh HL, Spiecher DW, Wingfield PT, eds. Expression and purification of GST fusion proteins. Curr Protoc Protein Sci. Hoboken: John Wiley & Sans, 2001: Chapter 6: Unit 6; 1-26.
30. Torchilin VP, Levchenko TS. TAT-liposomes: A novel intracellular drug carrier. Curr Protein Pept Sci 2003; 4: 133-40.